Importer of Controlled Substances; Notice of Registration, 7476 [E9-3392]

Download as PDF 7476 Federal Register / Vol. 74, No. 30 / Tuesday, February 17, 2009 / Notices DEPARTMENT OF JUSTICE Supplemental Notice of Lodging of Consent Decree Under the Clean Water Act On January 14, 2009, the Department of Justice published notice of the December 31, 2008, lodging of a proposed consent in United States and State of Oregon v. Pacific Northern Environmental Corp., dba Dedicated Fuels, Inc., Civil Action No. 3:08–cv– 01513–HU (D. Or.). See 74 FR 2101 (Jan. 14, 2009). The United States hereby supplements its notice because Appendix A to the proposed consent decree was omitted from the document when it was made available for public inspection. The period for submitting any comment on the proposed consent decree, including Appendix A, is hereby extended for a period of ten (10) days after the date of publication of this Supplemental Notice. Robert E. Maher, Jr., Assistant Section Chief, Environmental Enforcement Section. [FR Doc. E9–3217 Filed 2–13–09; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE sroberts on PROD1PC70 with NOTICES Notice of Lodging of Consent Decree Under the Clean Air Act, Comprehensive Environmental Response, Compensation, and Liability Act, and Emergency Planning and Community Right-To-Know Act Notice is hereby given that on February 10, 2009, a proposed Consent Decree in United States, et al. v. Hermes Consolidated, Inc. dba Wyoming Refining Company, Civil Action No. 09– CV–00028–ABJ was lodged with the United States District Court for the District of Wyoming. The Consent Decree in this enforcement action against Hermes Consolidated, Inc. (‘‘Hermes’’), resolves allegations by the Environmental Protection Agency, asserted in a complaint filed together with the Consent Decree, under Sections 113(b) and 167 of the Clean Air Act, 42 U.S.C. 7413(b) and 7477, Section 109(c) of the Comprehensive Environmental Response, Compensation, and Liability Act, 42 U.S.C. 9609(c), and Section 325(b) of the Emergency Planning and Community Right-to-Know Act, 42 U.S.C. 11045(b), for alleged environmental violations at Hermes’s petroleum refinery in Newcastle, Wyoming. The proposed Consent Decree also resolves separate but related VerDate Nov<24>2008 19:45 Feb 13, 2009 Jkt 217001 state law claims brought by the State of Wyoming, which has intervened in this matter. This is one of numerous national settlements reached as part of the EPA’s National Petroleum Refinery Initiative. Consistent with the objectives of EPA’s initiative, in addition to the payment of civil penalties, the settlement will require Hermes to perform injunctive relief to reduce emissions of nitrogen oxide, sulfur dioxide, volatile organic compounds, particulate matter, and carbon monoxide at the refinery. Also, the refinery will upgrade its leak detection and repair program to reduce emissions from pumps and valves. The Department of Justice will receive for a period of thirty (30) days from the date of this publication comments relating to the settlement. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and either e-mailed to pubcommentees.enrd@usdoj.gov or mailed to P.O. Box 7611, U.S. Department of Justice, Washington, D.C. 20044–7611, and should refer to United States, et al. v. Hermes Consolidated, Inc., Civil Action No. 09–CV–00028–ABJ, D.J. Ref. 90–5– 2–1–08001. The Consent Decree may be examined at: the United States Attorney’s Office for the District of Wyoming, 2120 Capitol Avenue—4th Floor, Cheyenne, Wyoming 82001 (request USAO File Number 2006V00090) and U.S. EPA Region 8, 1595 Wynkoop Street, Denver, Colorado 80202–1129 (contact David Rochlin at 303–312–6892). During the public comment period, the Consent Decree may also be examined on the following Department of Justice Web site, https://www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the Consent Decree may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $26.00 (25¢ per page reproduction cost) payable to the U.S. Treasury or, if by e-mail or fax, forward a check in that amount to the Consent Decree Library at the stated address. DEPARTMENT OF JUSTICE Robert Brook, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. E9–3233 Filed 2–13–09; 8:45 am] By Notice dated November 26, 2008, and published in the Federal Register on December 5, 2008, (73 FR 74195), Tocris Cookson, Inc., 16144 Westwoods Business Park, Ellisville, Missouri 63021–4500, made application by BILLING CODE 4410–15–P PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated February 20, 2008, and published in the Federal Register on February 29, 2008 (73 FR 11148), Meridian Medical Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Morphine (9300), a basic class of controlled substance listed in schedule II. The company plans to import products for research experimentation or clinical use and analytical testing. One objection was received; however, it has subsequently been withdrawn. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Meridian Medical Technologies to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Meridian Medical Technologies to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: February 9, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–3392 Filed 2–13–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 74, Number 30 (Tuesday, February 17, 2009)]
[Notices]
[Page 7476]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3392]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated February 20, 2008, and published in the Federal 
Register on February 29, 2008 (73 FR 11148), Meridian Medical 
Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Morphine (9300), a basic class of 
controlled substance listed in schedule II.
    The company plans to import products for research experimentation 
or clinical use and analytical testing.
    One objection was received; however, it has subsequently been 
withdrawn.
    DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and 
determined that the registration of Meridian Medical Technologies to 
import the basic class of controlled substance is consistent with the 
public interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Meridian Medical Technologies to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: February 9, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-3392 Filed 2-13-09; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.